MORNING CATEGORICAL COURSE
Cardiovascular Molecular MR Contrast Agents: from Bench to Bedside
Organizer: Peter Caravan, Ph.D.
Skill Level: Intermediate
Thursday 8 May and Friday 9 May 2008
This course of two one-hour sessions describes challenges broadly faced in using MR for molecular imaging and the technical advances that are meeting these challenges. Examples come from the cardiovascular field and describe successful application of molecular MRI in mouse and larger animal models and translation to clinical studies.
Upon completion of this course, participants should be able to:
This course is designed for physicists, chemists, molecular biologists, pharmacologists, Ph.D.-level imaging scientists, practicing clinicians, radiologists in private practice, training or academic centers, MRI technologists, graduate students, postdoctoral fellows, neuroradiologists, cardiologists, M.D. and Ph.D. scientists with an interest in cardiovascular disease, cardiovascular imaging, atherosclerosis, thromboembolic disease, molecular imaging, and contrast agents, and whose current work might include cardiovascular imaging, cardiovascular disease state models, and contrast agent design. No prior experience is required.
|7:00||Pushing the Contrast Sensitivity Envelope||Silvio Aime, Ph.D.|
|7:30||Molecular Imaging Using Multimodality (MR, PET, and CT) for Characterizing Atherosclerotic Plaque||Zahi A. Fayad, Ph.D.|
|7:00||Cardiovascular Molecular MRI in the Mouse||David Sosnovik, M.D.|
|7:30||Molecular MRI of Thrombosis: From Porcine Models to First Human Experiences||Elmar Spuentrup, M.D.|